JP2010525055A5 - - Google Patents

Download PDF

Info

Publication number
JP2010525055A5
JP2010525055A5 JP2010506110A JP2010506110A JP2010525055A5 JP 2010525055 A5 JP2010525055 A5 JP 2010525055A5 JP 2010506110 A JP2010506110 A JP 2010506110A JP 2010506110 A JP2010506110 A JP 2010506110A JP 2010525055 A5 JP2010525055 A5 JP 2010525055A5
Authority
JP
Japan
Prior art keywords
corm
medicament
manufacture
treatment
infectious diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010506110A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010525055A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/PT2008/000017 external-priority patent/WO2008130261A1/en
Publication of JP2010525055A publication Critical patent/JP2010525055A/ja
Publication of JP2010525055A5 publication Critical patent/JP2010525055A5/ja
Pending legal-status Critical Current

Links

JP2010506110A 2007-04-24 2008-04-24 一酸化炭素による感染症の処置 Pending JP2010525055A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92597607P 2007-04-24 2007-04-24
PCT/PT2008/000017 WO2008130261A1 (en) 2007-04-24 2008-04-24 Treatment of infections by carbon monoxide

Publications (2)

Publication Number Publication Date
JP2010525055A JP2010525055A (ja) 2010-07-22
JP2010525055A5 true JP2010525055A5 (https=) 2012-06-28

Family

ID=39720470

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506110A Pending JP2010525055A (ja) 2007-04-24 2008-04-24 一酸化炭素による感染症の処置

Country Status (4)

Country Link
US (1) US20100196516A1 (https=)
EP (1) EP2148688A1 (https=)
JP (1) JP2010525055A (https=)
WO (1) WO2008130261A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
NZ534912A (en) 2002-02-04 2007-08-31 Alfama Investigacao E Desenvol supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative
US7968605B2 (en) 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
GB2395432B (en) 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
AU2004262976A1 (en) * 2003-08-04 2005-02-17 Hemocorm Limited Use of boranocarbonates for the therapeutic delivery of carbon monoxide
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
EP2182961B1 (en) * 2007-07-24 2012-05-02 Alfama - Investigaçao e Desenvolvimento de Productos Farmaceuticos LDA. Prevention of gastric ulcery by carbon monoxide
EP2699242B1 (en) 2011-04-19 2017-11-01 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
JP6134710B2 (ja) * 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
DE102014008685A1 (de) * 2014-06-13 2015-12-17 Lorenz Meinel Freisetzungssystem für therapeutisches Gas
WO2016187545A1 (en) 2015-05-21 2016-11-24 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing venom related poisoning
WO2017015344A1 (en) * 2015-07-20 2017-01-26 University Of Vermont And State Agricultural College Use of cymanquine compounds as antimalarial agents
EP3524290A1 (en) 2018-02-09 2019-08-14 Julius-Maximilians-Universitaet Wuerzburg Method and system for monitoring carbon monoxide (co) administration to ex-vivo fluids
EP3808351A1 (en) 2019-10-14 2021-04-21 Julius-Maximilians-Universität Würzburg Membrane-based two component therapeutic gas release system for oral administration
EP3878471A1 (en) 2020-03-13 2021-09-15 Julius-Maximilians-Universitaet Wuerzburg Therapeutic system for the topic, transdermal and transcutaneous application of carbon monoxide
EP4275682A1 (en) * 2022-05-12 2023-11-15 Institut National De La Sante Et De La Recherche Medicale - Inserm Carbon monoxide-releasing molecule (corm) or composition thereof for use in the treatment or the prevention of an intestinal dysbiosis in a subject
US20260069629A1 (en) 2022-09-09 2026-03-12 Julius-Maximilians-Universität Würzburg, In Vertretung Des Freistaates Bayern Receptacle, device for releasing carbon monoxide, treatment system, set for treating living cells, method of treating a mammal, and carbon monoxide
CN119157883B (zh) * 2024-11-15 2025-02-14 温州医科大学附属口腔医院 一种抗菌剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065250A (en) * 1960-05-13 1962-11-20 Hercules Powder Co Ltd Nitrile-metal carbonyl complexes
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US20030068387A1 (en) * 2001-03-30 2003-04-10 Roland Buelow Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
NZ534912A (en) * 2002-02-04 2007-08-31 Alfama Investigacao E Desenvol supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative
CN1674942A (zh) * 2002-06-21 2005-09-28 联邦高等教育系统匹兹堡大学 氧化氮、血红素加氧酶－1和血红素降解产物的药学用途
ATE412684T1 (de) * 2002-09-09 2008-11-15 Nektar Therapeutics Al Corp Verfahren zur herstellung von wasserlöslichen polymerderivaten mit terminalen carboxylgruppen
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
AU2004262976A1 (en) * 2003-08-04 2005-02-17 Hemocorm Limited Use of boranocarbonates for the therapeutic delivery of carbon monoxide
US8148356B2 (en) * 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
US20070207993A1 (en) * 2005-12-20 2007-09-06 Alfama - Investigacao E Desenvolvimetno De Productos Farmaceuticos Lda Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases
GB0601394D0 (en) * 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
EP2099439A2 (en) * 2006-12-06 2009-09-16 Alfama - Investigação E Desenvolvimento De Produto Methods for treating inflammatory disease by administering aldehydes and derivatives thereof

Similar Documents

Publication Publication Date Title
JP2010525055A5 (https=)
JP2014530840A5 (https=)
HUE043175T2 (hu) Szintetikus triterpenoidok és alkalmazásuk betegség kezelésében
JP2009256391A5 (https=)
IL246697B (en) Multiple exon skipping compositions for use in treating muscular dystrophy
JP2010507682A5 (https=)
SMT201300007B (it) Trattamento di una malattia respiratoria
JP2013014622A5 (https=)
JP2015525757A5 (https=)
JP2009039101A5 (https=)
JP2011526809A5 (https=)
JP2012504217A5 (https=)
IL217540A (en) Oral composition for use in oral disinfection or in treating an oral disease
JP2011511805A5 (https=)
CL2008000461A1 (es) Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos.
PT2236149E (pt) Composição medicinal para o tratamento de doenças infeciosas respiratórias
JP2009215191A5 (https=)
JP2013181136A5 (ja) ポリイミド前駆体組成物、ポリイミド成形体、及び画像形成装置
JP2012501683A5 (https=)
JP2007520565A5 (https=)
JP2012516348A5 (https=)
JP2006305390A5 (https=)
JP2009532412A5 (https=)
JP2008519810A5 (https=)
JP2009001575A5 (https=)